share_log

BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Update

kopsource ·  Aug 2, 2022 19:02

BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) was the recipient of a large drop in short interest during the month of July. As of July 15th, there was short interest totalling 57,100 shares, a drop of 20.5% from the June 30th total of 71,800 shares. Based on an average daily volume of 47,100 shares, the days-to-cover ratio is presently 1.2 days.

BetterLife Pharma Stock Performance

BetterLife Pharma stock opened at $0.11 on Tuesday. BetterLife Pharma has a 52-week low of $0.05 and a 52-week high of $0.30. The firm has a 50 day moving average price of $0.09 and a two-hundred day moving average price of $0.12.

Get BetterLife Pharma alerts:

BetterLife Pharma (OTCMKTS:BETRF – Get Rating) last released its quarterly earnings results on Tuesday, June 28th. The company reported ($0.03) earnings per share (EPS) for the quarter.

BetterLife Pharma Company Profile

(Get Rating)

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.

Featured Stories

  • Get a free copy of the StockNews.com research report on BetterLife Pharma (BETRF)
  • Green Your Portfolio With These Stocks
  • Bloomin' Brands Is Blossoming
  • Is it Time to Cash Out of Signet Jewelers Stock?
  • MarketBeat Podcast: Find Investing Opportunities For The Rest of 2022
  • Deep Value High Yield Newell Brands Is Ready To Bottom

Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment